BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25030371)

  • 1. G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis.
    Marjon NA; Hu C; Hathaway HJ; Prossnitz ER
    Mol Cancer Res; 2014 Nov; 12(11):1644-1654. PubMed ID: 25030371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
    Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A
    Gene; 2023 Aug; 877():147548. PubMed ID: 37279863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What have we learned about GPER function in physiology and disease from knockout mice?
    Prossnitz ER; Hathaway HJ
    J Steroid Biochem Mol Biol; 2015 Sep; 153():114-26. PubMed ID: 26189910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
    Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
    Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
    Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
    Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
    Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment.
    Dong S; Ruiz-Calderon B; Rathinam R; Eastlack S; Maziveyi M; Alahari SK
    Int J Cancer; 2020 May; 146(9):2576-2587. PubMed ID: 31525254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding.
    Nayak TK; Ramesh C; Hathaway HJ; Norenberg JP; Arterburn JB; Prossnitz ER
    Mol Cancer Res; 2014 Nov; 12(11):1635-43. PubMed ID: 25030373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPER and ERα expression in abnormal endometrial proliferations.
    Tica AA; Tica OS; Georgescu CV; Pirici D; Bogdan M; Ciurea T; Mogoantă SŞ; Georgescu CC; Comănescu AC; Bălşeanu TA; Ciurea RN; Osiac E; Buga AM; Ciurea ME
    Rom J Morphol Embryol; 2016; 57(2):413-8. PubMed ID: 27516013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
    Sundaram S; Yan L
    J Nutr Biochem; 2020 Mar; 77():108313. PubMed ID: 31837540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis.
    Filardo EJ
    J Steroid Biochem Mol Biol; 2018 Feb; 176():38-48. PubMed ID: 28595943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation.
    Molina L; Bustamante F; Ortloff A; Ramos I; Ehrenfeld P; Figueroa CD
    Front Endocrinol (Lausanne); 2020; 11():563165. PubMed ID: 33117280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis.
    Davis KE; Carstens EJ; Irani BG; Gent LM; Hahner LM; Clegg DJ
    Horm Behav; 2014 Jun; 66(1):196-207. PubMed ID: 24560890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast.
    Scaling AL; Prossnitz ER; Hathaway HJ
    Horm Cancer; 2014 Jun; 5(3):146-160. PubMed ID: 24718936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs).
    Vivacqua A; De Marco P; Santolla MF; Cirillo F; Pellegrino M; Panno ML; Abonante S; Maggiolini M
    Oncotarget; 2015 Jun; 6(18):16573-87. PubMed ID: 26030000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.